Evidence map›Paper›PMID 36296891›Full record

ArticleNanomaterials (Basel, Switzerland)2022

Advances in Nanomaterials for Photovoltaic Applications.

Vlad-Andrei Antohe

Abstract readEditorial
In one paragraph

Article in Nanomaterials (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Vlad-Andrei AntoheResearch and Development Center for Materials and Electronic & Optoelectronic Devices (MDEO), Faculty of Physics, University of Bucharest, 077125 Măgurele, Ilfov, Romania.ORCID 0000-0003-2298-0719

Funding

Unitatea Executiva Pentru Finantarea Invatamantului Superior a Cercetarii Dezvoltarii si Inovarii 115/2020 (PN-III-P1-1.1-TE-2019-0868)
6 · The paper itself

Abstract

The development of novel nanomaterials became a subject of intensive research, due to high market needs for innovative applications in virtually all aspects of life [...].

Identifiers

PMID36296891
PMCPMC9611635

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.